FBXL16 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-57613
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to FBXL16(F-box and leucine-rich repeat protein 16) The peptide sequence was selected from the middle region of FBXL16.
Peptide sequence GCPLLTTTGLSGLVQLQELEELELTNCPGATPELFKYFSQHLPRCLVIE. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for FBXL16 Antibody
Western Blot: FBXL16 Antibody [NBP1-57613]
Western Blot: FBXL16 Antibody [NBP1-57613] - Hela cell lysate, concentration 0.2-1 ug/ml.Applications for FBXL16 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FBXL16
Alternate Names
C16orf22, c380A1.1, c380A1.1 (novel protein), chromosome 16 open reading frame 22, FBL16, F-box and leucine-rich repeat protein 16Fbl16, F-box/LRR-repeat protein 16, FLJ33735, MGC33974
Gene Symbol
FBXL16
UniProt
Additional FBXL16 Products
Product Documents for FBXL16 Antibody
Product Specific Notices for FBXL16 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...